Peter‐Andreas Löschmann

Author

University of Tübingen

Also Known As

Peter-Andreas Löschmann, Peter‐Andreas Löschmann

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Tübingen Pfizer (Germany)

About

Peter‐Andreas Löschmann is an author at University of Tübingen specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1K
2	Health Sciences	2	2	132
3	Social Sciences	2	2	82
4	Biochemistry	1	1	40
5	Immunology	1	1	70

Peter‐Andreas Löschmann

Publications

Citations

H-Index

Page 1

	Year	Citations
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists Lechosław Turski, Karin Bressler, Klaus Jürgen Rettig, Nature Substantia NigraMedicinePsychotropic MedicationNeuropharmacologyPharmacotherapy	1991	549
Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease Peter‐Andreas Löschmann, Carmen de Groote, Lance A. Smith, Experimental Neurology MedicineAnimal ModelsNeuropharmacologyNeuroprotectionNeuroscience	2004	99
Kainate Microinjection into the Dorsal Raphe Nucleus Induces 5-HT Release in the Amygdala and Periaqueductal Gray Milena de Barros Viana, Frederico Guilherme Graeff, Peter‐Andreas Löschmann Pharmacology Biochemistry and Behavior 5-Ht ReleaseNeurobiological MechanismNeurophysiologyNeuroanatomyPhysiology	1997	74
Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice Andreas Kupsch, Peter‐Andreas Löschmann, H. Sauer, Brain Research NeuropeptidesMedicineImmunologyImmunocytochemical AnalysesMechanism Of Action	1992	70
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy- piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats H. Wachtel, Margrit Kunow, Peter‐Andreas Löschmann Neuroscience Letters Substantia NigraNeurophysiologyMedicineFunctional SelectivityPhysiology	1992	58
Effects of 7-nitroindazole, NG-nitro-l-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-d-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions Frank Eblen, Peter‐Andreas Löschmann, Ullrich Wüllner, European Journal of Pharmacology Nigral 6-Hydroxydopamine LesionsPsychoactive DrugHarmaline-induced Postural TremorNeurophysiologyMedicine	1996	47
Use of Dipeptides for the Synthesis of Glutathione by Astroglia‐Rich Primary Cultures Ralf Dringen, Oliver Kranich, Peter‐Andreas Löschmann, Journal of Neurochemistry Astroglia‐rich Primary CulturesBiochemistryMedicinePhysiologyGlutathione Restoration	1997	40
Effects of the antiparkinsonian drug budipine on central neurotransmitter systems Thomas Klockgether, Ullrich Wüllner, Joachim P. Steinbach, European Journal of Pharmacology NeurophysiologyMedicineNeurotransmitterNeuropeptide ReceptorNeuropharmacology	1996	35
Therapy of 1,025 Severely Ill Patients with Complicated Infections in a German Multicenter Study: Safety Profile and Efficacy of Tigecycline in Different Treatment Modalities Klaus‐Friedrich Bodmann, W. R. Heizmann, Christof von Eiff, Chemotherapy	2012	30
Lamotrigine has no antiparkinsonian activity in rat models of Parkinson's disease Peter‐Andreas Löschmann, Frank Eblen, Ullrich Wüllner, European Journal of Pharmacology MedicineRat ModelsNeuropharmacologyNeuroprotectionNeurology	1995	17

Page 1